33. Consolidated Companies as of December 31, 2024
Name of the subsidiary |
Country |
% voting right |
Change in % voting |
|---|---|---|---|
Continuing operations |
|
|
|
GLPG US Inc. (formerly AboundBio Inc.) |
United States |
100% |
|
Galapagos B.V. (merged with CellPoint B.V.) |
The Netherlands |
100% |
|
Galapagos GmbH |
Switzerland |
100% |
|
GLPG US Holding Inc. (formerly Galapagos Inc.) |
United States |
100% |
|
Galapagos NV |
Belgium |
Parent company |
|
Galapagos Real Estate Belgium BV |
Belgium |
100% |
|
Galapagos Real Estate Netherlands B.V. |
The Netherlands |
100% |
|
Galapagos U.K. Limited |
United Kingdom |
100% |
100% |
Galapagos SASU |
France |
100% |
|
Xenometrix, Inc. in liquidation |
United States |
100% |
|
Galapagos Holding PTE. LTD. |
Singapore |
100% |
100% |
|
|
|
|
Discontinued operations |
|
|
|
Galapagos Biopharma Belgium BV |
Belgium |
0% |
(100%) |
Galapagos Biopharma Netherlands B.V. |
The Netherlands |
0% |
(100%) |
Galapagos Biopharma Spain S.L.U. |
Spain |
0% |
(100%) |
Galapagos Biopharma Italy S.r.l. |
Italy |
0% |
(100%) |
Galapagos Biopharma Germany GmbH |
Germany |
0% |
(100%) |
Galapagos Biopharma Sweden AB |
Sweden |
0% |
(100%) |
Galapagos Biopharma Norway AS |
Norway |
0% |
(100%) |
Galapagos Biopharma Finland Oy |
Finland |
0% |
(100%) |
Galapagos Biopharma Denmark ApS |
Denmark |
0% |
(100%) |
Galapagos Biopharma Austria GmbH |
Austria |
0% |
(100%) |
Galapagos Biopharma Ireland Ltd |
Ireland |
0% |
(100%) |
Galapagos Biotech Ltd |
United Kingdom |
0% |
(100%) |
There are no significant restrictions on the group’s ability to access or use assets, or settle liabilities, of one of the group’s subsidiaries.
In December 2024, we signed a share purchase agreement regarding the shares of Galapagos Real Estate Belgium BV. We expect closing of the transaction by March 31, 2025.
On January 7, 2025, we incorporated Galapagos (Shanghai) Bioscience Co., Ltd., in the People’s Republic of China, and on February 14, 2025 we incorporated XYZ SpinCo NV.